118 related articles for article (PubMed ID: 3545855)
21. In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF.
Spillantini MG; Geppetti P; Fanciullacci M; Michelacci S; Lecomte JM; Sicuteri F
Eur J Pharmacol; 1986 Jun; 125(1):147-50. PubMed ID: 3015640
[TBL] [Abstract][Full Text] [Related]
22. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition.
Patey G; De La Baume S; Schwartz JC; Gros C; Roques B; Fournie-Zaluski MC; Soroca-Lucas E
Science; 1981 Jun; 212(4499):1153-5. PubMed ID: 7015510
[TBL] [Abstract][Full Text] [Related]
23. Enkephalinase 'A' inhibition by thiorphan: central and peripheral cardiovascular effects.
Baum T; Becker FT; Sybertz EJ; Sabin C; Desiderio DM
Eur J Pharmacol; 1983 Oct; 94(1-2):85-91. PubMed ID: 6360696
[TBL] [Abstract][Full Text] [Related]
24. Enkephalinase (EC 3.4.24.11) is highly localized to a striatonigral pathway in rat brain.
Pollard H; Llorens-Cortes C; Couraud JY; Ronco P; Verroust P; Schwartz JC
Neurosci Lett; 1987 Jun; 77(3):267-71. PubMed ID: 2441326
[TBL] [Abstract][Full Text] [Related]
25. 1H NMR configurational correlation for retro-inverso dipeptides: application to the determination of the absolute configuration of "enkephalinase" inhibitors. Relationships between stereochemistry and enzyme recognition.
Fournié-Zaluski MC; Lucas-Soroca E; Devin J; Roques BP
J Med Chem; 1986 May; 29(5):751-7. PubMed ID: 3517331
[TBL] [Abstract][Full Text] [Related]
26. Detailed immunoautoradiographic mapping of enkephalinase (EC 3.4.24.11) in rat central nervous system: comparison with enkephalins and substance P.
Pollard H; Bouthenet ML; Moreau J; Souil E; Verroust P; Ronco P; Schwartz JC
Neuroscience; 1989; 30(2):339-76. PubMed ID: 2473416
[TBL] [Abstract][Full Text] [Related]
27. [Enkephalinase inhibitors and molecular study of the differences between active sites of enkephalinase and angiotensin-converting enzyme].
Roques BP
J Pharmacol; 1985; 16 Suppl 1():5-31. PubMed ID: 2993752
[TBL] [Abstract][Full Text] [Related]
28. Origin of the stimulation of food intake by oral administration of enkephalinase inhibitors in sheep.
Rivière PJ; Buéno L
Life Sci; 1987 Jul; 41(3):333-9. PubMed ID: 3298911
[TBL] [Abstract][Full Text] [Related]
29. Enkephalinase inhibitor potentiates substance P- and electrically induced contraction in ferret trachea.
Sekizawa K; Tamaoki J; Nadel JA; Borson DB
J Appl Physiol (1985); 1987 Oct; 63(4):1401-5. PubMed ID: 2447055
[TBL] [Abstract][Full Text] [Related]
30. [Regional distribution of enkephalinase in the rat brain by autoradiography].
Waksman G; Hamel E; Bouboutou R; Besselièvre R; Fournié-Zaluski MC; Roques BP
C R Acad Sci III; 1984; 299(14):613-5. PubMed ID: 6440665
[TBL] [Abstract][Full Text] [Related]
31. Biochemical and immunological properties of a membrane-bound brain metalloendopeptidase: comparison with thermolysin-like kidney neutral metalloendopeptidase.
Almenoff J; Orlowski M
J Neurochem; 1984 Jan; 42(1):151-7. PubMed ID: 6417277
[TBL] [Abstract][Full Text] [Related]
32. Enkephalinase is involved in the degradation of endogenous substance P released from slices of rat substantia nigra.
Mauborgne A; Bourgoin S; Benoliel JJ; Hirsch M; Berthier JL; Hamon M; Cesselin F
J Pharmacol Exp Ther; 1987 Nov; 243(2):674-80. PubMed ID: 2445957
[TBL] [Abstract][Full Text] [Related]
33. Effect of bestatin and thiorphan on [Met5]enkephalin-Arg6-Phe7-induced analgesia.
Reggiani A; Carenzi A; Frigeni V; Della Bella D
Eur J Pharmacol; 1984 Oct; 105(3-4):361-4. PubMed ID: 6391939
[TBL] [Abstract][Full Text] [Related]
34. Purification and characterization of enkephalinase, angiotensin converting enzyme, and a third peptidyldipeptidase from rat brain.
Cushman DW; Gordon EM; Wang FL; Cheung HS; Tung R; Delaney NG
Life Sci; 1983; 33 Suppl 1():25-8. PubMed ID: 6319870
[TBL] [Abstract][Full Text] [Related]
35. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo.
Mendelsohn LG; Johnson BG; Scott WL; Frederickson RC
J Pharmacol Exp Ther; 1985 Aug; 234(2):386-90. PubMed ID: 3894620
[TBL] [Abstract][Full Text] [Related]
36. Comparison of [125I]beta-endorphin binding to rat brain and NG108-15 cells using a monoclonal antibody directed against the opioid receptor.
Bidlack JM; O'Malley WE; Schulz R
Mol Pharmacol; 1988 Feb; 33(2):170-7. PubMed ID: 2828912
[TBL] [Abstract][Full Text] [Related]
37. Depressive effects of morphine and of an enkephalinase inhibitor on responses of ventro-basal thalamic neurones to noxious stimuli.
Guilbaud G; Kayser V; Benoist JM; Gautron M
Life Sci; 1983; 33 Suppl 1():545-7. PubMed ID: 6363853
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the role of "enkephalinase" in cholecystokinin inactivation.
Zuzel KA; Rose C; Schwartz JC
Neuroscience; 1985 May; 15(1):149-58. PubMed ID: 3892359
[TBL] [Abstract][Full Text] [Related]
39. The endogenous tripeptide Tyr-Gly-Gly as a possible metabolite of opioid peptides in rat brain: identification, regional distribution, effects of lesions and formation in depolarized slices.
Giros B; Llorens-Cortes C; Gros C; Schwartz JC
Peptides; 1986; 7(4):669-77. PubMed ID: 3532054
[TBL] [Abstract][Full Text] [Related]
40. Neuronal localization of the neutral endopeptidase 'enkephalinase' in rat brain revealed by lesions and autoradiography.
Waksman G; Hamel E; Delay-Goyet P; Roques BP
EMBO J; 1986 Dec; 5(12):3163-6. PubMed ID: 3545813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
